Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV



Status:Completed
Conditions:Infectious Disease, HIV / AIDS, Women's Studies, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Reproductive
Healthy:No
Age Range:12 - 24
Updated:3/1/2017
Start Date:September 2011
End Date:June 2012

Use our guide to learn which trials are right for you!

Behavioral, Immunologic and Virologic Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV-Infection

The proposed study is a substudy of ATN 106 and a cross sectional study intended to be
conducted at each of the AMTUs newly participating in ATN III. The intent is to enroll all
youth with behaviorally-acquired HIV who have enrolled in ATN 106. The study involves a
review of the subjects' medical chart and a collection of an oral rinse sample.

ATN 114 is a cross-sectional substudy of ATN 106. In addition to sharing data collected in
ATN 106, an oral rinse sample along with the subject's self reported history and medical
chart abstraction of HPV vaccination status and medical chart abstraction of a history of
oral condylomata, oral dysplasia and oral tumor viruses will be collected in ATN 114.

Recruitment is expected to last approximately one year, similar to the same timeframe for
ATN 106. Enrollment may be terminated earlier at the discretion of the ATN Executive
Committee and/or the ATN 114 protocol team should ATN 106 also terminate enrollment early.
Individuals who have agreed to participate in ATN 106 may be simultaneously approached at
any clinic visit, or, for community-based sites, contacted directly for participation in ATN
114. Site staff may also contact individuals via phone, e-mail, or any other agreed-upon
methods of communication. Site staff should try as much as possible to incorporate the study
visit into a regularly scheduled clinic visit.

Inclusion Criteria

- Behaviorally acquired HIV-infection as indicated by medical chart abstraction or
self-reported history of sexual risk and/or needle using behaviors; and

- Completion of the ATN 106 study visit (the same day or up to a maximum of 14 calendar
days).

Exclusion Criteria

- Presence of serious psychiatric symptoms (e.g., active hallucinations, thought
disorder) that would impair the individual's ability to complete the study measures;

- Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior); or

- Intoxicated or under the influence of alcohol or other substances at the time of
consent/assent for ATN 114.
We found this trial at
5
sites
13001 E. 17th Pl
Aurora, Colorado 80045
303-724-5000
University of Colorado Denver The University of Colorado Denver | Anschutz Medical Campus provides a...
?
mi
from
Aurora, CO
Click here to add this to my saved trials
3400 N Charles St
Baltimore, Maryland 21205
410-516-8000
Johns Hopkins University The Johns Hopkins University opened in 1876, with the inauguration of its...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
1200 Moursund Street
Houston, Texas 77030
(713) 798-4951
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
?
mi
from
Houston, TX
Click here to add this to my saved trials
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
3901 Beaubien St
Detroit, Michigan 48201
(313) 745-5437
Children's Hospital of Michigan Since 1886, the Children's Hospital of Michigan has been dedicated to...
?
mi
from
Detroit, MI
Click here to add this to my saved trials